Suresh Guduru
Suresh Guduru was appointed as Chairman and Chief Executive Officer
Highest-materiality recent filing
Piermont Valley SPAC to merge with insurtech Tigerless Health at $280M enterprise value
Enterprise value of ~$280M; existing Tigerless shareholders roll 100% of equity into combined company.
Piermont Valley Acquisition Corp change in control; new CEO Wei Qian appointed
Share Purchase Agreement transfers 2,238,999 Class A and 1 Class B share to Valleypark Road, LLC for $100.
Shareholders approved extension of business combination deadline from March 3, 2025 to March 3, 2026.
Non-redemption agreement with unaffiliated shareholder covers 200,000 Class A ordinary shares.
Nasdaq to delist Capitalworks Emerging Markets Acquisition Corp; Form 25 filing imminent
Nasdaq notified on Aug 31, 2024 it will file Form 25 to complete delisting.
Nasdaq to delist Capitalworks EM Acquisition Corp from June 12 for minimum holders rule breach
Nasdaq notified the Company on June 10, 2024, that trading will be suspended at open on June 12, 2024.
New Sponsor bought 3,925,000 Class A shares, 7,605,000 warrants, and 1 Class B share from prior sponsor for undisclosed consideration.
Capitalworks EM receives Nasdaq delisting notice for failing minimum holder rule
Nasdaq notified Capitalworks EM on April 18, 2024 that it did not regain compliance with the 400 total holders rule.
Capitalworks EM Acquisition Corp terminates business combination with Lexasure
SPAC and Lexasure mutually agreed to terminate Business Combination Agreement on March 22, 2024.
SPAC extends business combination deadline to March 2025; ~$33.6M redeemed
Extension Amendment approved: deadline for business combination moved from March 3, 2024 to March 3, 2025.
Capitalworks SPAC enters non-redemption agreements to extend deadline to March 2025
Holders agree not to redeem 1,025,000 Class A shares; sponsor to forfeit up to 307,500 founder shares.
SPAC shareholders approve extension to March 3, 2024; $197M redeemed
Extension from June 3, 2023 to March 3, 2024 approved; board may elect earlier liquidation.
CEMAC seeks nine-month extension to March 3, 2024 to close Lexasure deal; shareholder vote May 23
Shareholder meeting scheduled for May 23, 2023 to approve extension of business combination deadline to March 3, 2024.
CEMAC agrees to acquire Lexasure Financial Group in SPAC merger valued at $250M
Total consideration of $250M plus any net proceeds from new investments; consideration paid in Pubco ordinary shares.
CEMAC (NASDAQ: CMCA) entered a definitive business combination agreement with Lexasure Financial Group.
Extraordinary general meeting postponed indefinitely; was to vote on extending deadline from March 3, 2023 to Dec 3, 2023.
Sponsor transfers 16,000 Founder Shares upfront and up to 480,000 additional Founder Shares to third parties for agreeing not to redeem up to 1,600,000 Class A shares.
Capitalworks postpones SPAC extension vote to March 1; deadline extended to Dec 3
Extraordinary general meeting postponed from Feb 24 to March 1, 2023 at 4:00 p.m. ET.
Capitalworks restates Dec 2021 balance sheet and Q4 2021 financials; material weakness
Non-reliance on Dec 3, 2021 audited balance sheet and Q4 2021 unaudited interim financials.
SPAC Capitalworks completes $230M IPO, $11.7M private placement, deposits $234.6M in trust
Completed IPO of 23,000,000 units at $10.00 per unit for gross proceeds of $230,000,000.
SPAC Capitalworks raises $230M in IPO; $234.6M placed in trust
IPO of 23M units at $10.00 each, gross proceeds $230M, includes full over-allotment.
Suresh Guduru was appointed as Chairman and Chief Executive Officer
Suresh Singamsetty was appointed as a director
Brian Coad was appointed as a director and Chief Financial Officer
John Levy was appointed as a director
Brian Coad was appointed as a director and Chief Financial Officer
Suresh Guduru was appointed as Chairman and Chief Executive Officer
Kishore Kondragunta was appointed as a director
On February 23, 2024, Michael Faber tendered his resignation as a director of Capitalworks Emerging Markets Acquisition Corp (the “ Company ”) , effective immediately.
Effective as of November 30, 2021, the following individuals were appointed to the board of directors of the Company: Whitney Baker, Michael Faber, Neil Harper and Darius James Roth.
Effective as of November 30, 2021, the following individuals were appointed to the board of directors of the Company: Whitney Baker, Michael Faber, Neil Harper and Darius James Roth.
Effective as of November 30, 2021, the following individuals were appointed to the board of directors of the Company: Whitney Baker, Michael Faber, Neil Harper and Darius James Roth.
Effective as of November 30, 2021, the following individuals were appointed to the board of directors of the Company: Whitney Baker, Michael Faber, Neil Harper and Darius James Roth.
Max materiality 0.90 · Median 0.65 · Most common event other_material